EXPO
Exponent, Inc.74.20
-0.48-0.64%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
3.75BP/E (TTM)
36.55Basic EPS (TTM)
2.03Dividend Yield
0.02%Recent Filings
10-Q
8-K
Q3 revenues surge 10%
Exponent reported Q3 2025 revenues before reimbursements up 10% to $137.1 million, with net income rising to $28.0 million or $0.55 per share, fueled by dispute work in energy and transportation yet offset by softer consumer electronics. The board declared a $0.30 quarterly dividend payable December 19 and boosted share repurchase authorization by $100 million atop $21.6 million remaining. Strong cash flows enable this return. Guidance holds for low-single-digit full-year revenue growth.
10-Q
Q2 FY2025 results
Exponent's Q2 revenues edged up 1% year-over-year to $142M, driven by higher billing rates in engineering and scientific services amid softer demand in environmental health, while billable hours dipped 6% to 359,000 and utilization slipped to 72%. Operating income fell 52% to $17M due to elevated compensation from salary hikes and deferred comp swings, yet net income held at $27M with diluted EPS of $0.52 on 51.5M shares—anti-dilution excluded 176K options. Free cash flow came in at $39M (derived), supporting $232M in cash despite $33M in stock buybacks and dividends. The Arizona land lease extension through 2043 adds predictable occupancy costs. Volatility in deferred comp assets remains a quirk. Competition from larger consultancies pressures margins.
8-K
Flat Q2 revenues, dividend declared
Exponent reported Q2 2025 revenues before reimbursements flat at $132.9 million, with net income dipping to $26.6 million or $0.52 per share amid higher compensation costs, yet dispute services grew in construction, automotive, and medical devices. The board declared a $0.30 quarterly dividend, payable September 19 to record holders on September 5, underscoring capital return focus. Momentum builds in digital health and AI. Risks include economic shifts curbing demand.
8-K
Annual meeting elects directors
Exponent, Inc. held its annual stockholder meeting on June 5, 2025, electing seven directors including George H. Brown, Catherine Ford Corrigan, Ph.D., and others, with strong support exceeding 42 million votes for each. Stockholders ratified KPMG LLP as auditors for fiscal 2025 and approved executive compensation for fiscal 2024 on an advisory basis. Karen Richardson steps up as Lead Independent Director. Governance stays steady.
IPO
Website
Employees
Sector
Industry